The role of nursing team continuity in the treatment of very-low-birth-weight infants: findings from a pilot study

2015 ◽  
Vol 24 (4) ◽  
pp. 458-464 ◽  
Author(s):  
Felix Miedaner ◽  
Antje Allendorf ◽  
Ludwig Kuntz ◽  
Christiane Woopen ◽  
Bernhard Roth
2019 ◽  
Vol 37 (07) ◽  
pp. 716-721 ◽  
Author(s):  
Deepak Sharma ◽  
Amandeep Kaur ◽  
Nazanin Farahbakhsh ◽  
Sunil Agarwal

Objective This study aimed to study the role of oropharyngeal administration of colostrum (OAC) in very-low-birth-weight infants for reducing necrotizing enterocolitis (NEC). Study Design In this randomized controlled trial, 117 infants were enrolled, 59 were randomized to OAC group and 58 to routine care group. Infants with birth weight ≤ 1,250 g and/or gestational age ≤ 30 weeks were enrolled. Infants in OAC group received maternal colostrum (0.2 mL), 0.1 mL on either side, after 24 hours of postnatal life and were given every 2 hour for the next 72 hours irrespective of the enteral feeding status of the neonate. The primary outcome of the study was the incidence of NEC (stage 2 or 3). Results Baseline characteristics were comparable between the two groups. There was no significant reduction in the incidence of NEC in OAC group (0 [0%] vs. 3 [7.1%]; p = 0.11). There was significant reduction of 7 days of hospital stay in OAC group (34.2 ± 5.7 vs. 41.5 ± 6.7 days; p = 0.04).The incidence of early-onset sepsis, late-onset sepsis, blood culture positive sepsis, and ventilator-associated pneumonia were comparable between the two groups. Conclusion OAC is safe and reduces the duration of hospital stay.


2009 ◽  
Vol 48 (4) ◽  
pp. 437-442 ◽  
Author(s):  
Enrico Bertino ◽  
Francesca Giuliani ◽  
Giovanna Prandi ◽  
Alessandra Coscia ◽  
Claudio Martano ◽  
...  

2010 ◽  
Vol 41 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Ran D. Goldman ◽  
Abraham Spierer ◽  
Alexander Zhurkovsky ◽  
Jacob Kwint ◽  
Monica Schwarcz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document